PRODUCTS
SERVICES
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
2.12
3 yrs 1 m
1%
3,665.74 Crs
1% on or before 30D, Nil after 30D
Large Growth
8.41
SIP 100 & Lumpsum 100
BSE HEALTH CARE - TRI
Nikhil Mathur
Investors understand that their principal will be at very high risk